Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...

Alzheimer’s experts welcomed the study but noted weight loss jabs combat diabetes and obesity, both of which can contribute to the development of dementia | ITV National News ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...